Help accelerate mRNA therapeutics research and commercialization by sourcing the right raw materials. Thermo Fisher Scientific helps provide a wide range of products and services throughout every stage of your mRNA therapeutic development cycle such as research and discovery, pre-clinical development, clinical development, and commercial manufacturing.

Linear chevron process showing the three stages of drug development

Figure 1. mRNA manufacturing workflow


Quality grades for RNA-based drug development

  • Standard grade—Supporting RNA discovery and research. Wide selection of materials for basic RNA research. These high-quality reagents usually contain animal origin (AO) components in their formulations and production process and are supported with standard quality documentation package.
  • TheraPure grade—Advancing early development and process optimization. TheraPure grade materials are an exceptional choice for your initial stages of RNA drug manufacturing process development, optimization, and preclinical studies. The portfolio of animal origin free (AOF) and beta lactam free materials support a smooth transition to TheraPure GMP as it utilizes the same molecule and composition as in TheraPure GMP reagents. 
  • TheraPure GMP grade—Designed to meet clinical and commercial demands. As your mRNA production progresses toward clinical trials and commercial cGMP manufacturing, you can easily transition to TheraPure GMP materials—manufactured with stringent process and quality controls and accompanied by comprehensive documentation to support regulatory submissions. Watch this quality tour video to learn more.

Quality grades of products differ in variety of attributes, manufacturing processes, quality control documentation package available. See Table 1 for main attributes.

Table 1. Attributes of the various grades of raw materials used in mRNA manufacturing

Product StandardTheraPureTheraPure GMP
AOF (animal origin free) and beta-lactam free process and materialsNoYesYes
AOF and beta-lactam free facilityNoNoYes
Manufacture and documentation follow ICH Q7 guidelinesNoNoYes
Validated product-specific manufacturing processes and analytical methodsNoNoYes
Product-specific stabilityNoNoYes
Impurity testing, including melamine and nitrosamineNoNoYes
Quality documentationCoA, CoOCoA, CoO, TSE/BSE statementCoA, CoO, TSE/BSE statement, impurity profiles
DMF (drug master file)NoNoYes
Recommended useResearch use onlyProof of concept, research, and pre-clinical developmentClinical and commercial manufacturing

Raw materials for RNA therapeutics: From development to production

mRNA production involves DNA template preparation, in vitro transcription (IVT), mRNA modification, and DNA and protein removal steps. Our innovative solutions and custom services are designed to meet your specific quality, purity requirements, and scalable batch-to-batch consistency.

DNA template preparation in vitro

In vitro DNA templates can be produced using techniques such as rolling circle amplification (RCA) or PCR. RCA is a cell-free amplification method that is a promising alternative to traditional plasmid DNA and PCR amplification. RCA requires polymerases with strong displacement activity and dNTPs for strand synthesis; the reactions take place at constant temperature.

Product StandardTheraPureTheraPure GMP
Phi29 DNA polymeraseEP0091
TheraPure phi29 DNA Polymerase (10 U/μL)
-
dNTPsdNTP Set, 100 mM Solutions
-TheraPure GMP dNTPs

Plasmid DNA linearization

Plasmid DNA is linearized with restriction enzyme, and the linearized DNA is then used as a template for in vitro transcription to produce mRNA.

mRNA transcription

During IVT reaction, the DNA template, RNA polymerase, NTPs, RNase inhibitor, pyrophosphatase, and IVT buffer are critical components for mRNA production.

mRNA modification

Co-transcriptional or post-translational capping protects mRNA and promotes mRNA function. The poly-A tail addition stabilizes and prevents degradation of mRNA.

Product StandardTheraPureTheraPure GMP
Vaccinia Capping EnzymeModifying enzymes
TheraPure Vaccinia Capping Enzyme, 100 U/µL-
Vaccinia mRNA Cap 2'-O-MethyltransferaseModifying enzymes
TheraPure 2'-O-Methyltransferase (125 U/μL)-
S-Adenosyl-L-Methionine (SAM)Co-factors
TheraPure S-Adenosyl-L-Methionine (32 mM)Coming soon: TheraPure GMP  S-Adenosyl-L-methionine, 32 mM
Poly A polymerasePoly(A) Polymerase (cloned) 2 U/μL
--

DNA template and protein removal

After IVT, the DNA template can be removed using DNAse enzyme. Proteinase K might be used for protein removal.


Product development and manufacturing capabilities

Decorative

Technical expertise

50 years in enzyme and other reagent development have generated a substantial knowledge background that can be applied to further innovations.

Decorative

Manufacturing

Our facilities are equipped to support high-scale product manufacturing. The animal origin-free and beta-lactam free facility operates under ISO 9001 and follows applicable ICH Q7 guidelines, ensuring the highest standards of quality and safety for TheraPure GMP products.

Decorative

Quality

Implemented ISO9001 and/or ISO13485 quality management systems and extensive product testing ensures traceability, high product quality, and batch-to-batch consistency. 

Decorative

Supply chain

Different methods of transportation ensure smooth and safe product delivery directly to the customer or via a network of worldwide distribution centers.


Custom services for raw materials

Product customization icon
Product customization
  • ✓ Composition
  • Volume
  • Labeling
Quality icon
Quality
  • ✓ Additional quality attributes
  •  Stability studies
  •  Shelf-life extension
Product development icon
New product development
  • ✓ AOF product development
  •  GMP product development
  •  Your protein cloning, expression and purification 
Featured products: Rolling circle amplification solutions
  • The RCA method of isothermal amplification offers several advantages over traditional amplification methods, including faster performance, a cell-free process, a less complex protocol, and a lower risk of contamination. Explore RCA products for GMP mRNA production.

TheraPure phi29 DNA polymerase

TheraPure phi29 DNA polymerase

  • High activity and fidelity
  • Animal origin free (AOF)
  • Cost-effective

TheraPure phi29 DNA polymerase

TheraPure GMP dNTPs

  • High purity
  • Manufactured following ICH Q7 GMP guidelines
  • Validated production and QC process

* “TheraPure GMP” refers to the quality level of the raw, ancillary, or starting materials to be used for further manufacturing. TheraPure GMP products are manufactured in facilities with ISO 9001–certified quality management systems that operate in accordance with relevant good manufacturing practice (GMP) principles, as outlined in ICH Q7 or equivalent guidance documents or standards.

Stylesheet for Classic Wide Template adjustments